PEGylated leptin (Ambrx)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePEGylated leptin (Ambrx)
Drug Alias NamePEG-Leptin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLeptin receptor agonists
TargetsLeptin receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbrx Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A